Platinum-sensitive Ovarian Cancer
Oncology
Prevalence
24.0 / 100K
Incidence
10.6 / 100K/yr
4 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Platinum-sensitive Ovarian Cancer?
BioSniper tracks 4 drugs in development for Platinum-sensitive Ovarian Cancer across 2 companies.
How many clinical trials target Platinum-sensitive Ovarian Cancer?
There are 1 clinical trial targeting Platinum-sensitive Ovarian Cancer tracked by BioSniper.
What is the prevalence of Platinum-sensitive Ovarian Cancer?
The estimated prevalence of Platinum-sensitive Ovarian Cancer is approximately 24.0 per 100,000 population.
Deep-dive into Platinum-sensitive Ovarian Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis